OssDsign AB (SE0012570448)
XSTU 
Summary
SE0012570448 Chart
OssDsign AB (SE0012570448) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has OssDsign AB ever had a stock split?
OssDsign AB Profile
| Health Care Technology Industry | Healthcare Sector | Mr. Mark Waugh B.S., M.B.A. CEO | XSTU Exchange | SE0012570448 ISIN |
| SE Country | 35 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
OssDsign AB (publ) operates in the high-tech medical device sector, focusing on the development, manufacturing, and distribution of innovative implant and material technologies aimed at bone regeneration and healing. The company has carved a niche for itself through its specialized product offerings catered to cranial surgeries and bone growth stimulation, primarily servicing markets in Sweden, Germany, the United States, the United Kingdom, the rest of Europe, and beyond on an international scale. Founded in 2011, OssDsign is based in Uppsala, Sweden, and continues to advance in the field of regenerative medicine by leveraging state-of-the-art technology and scientific research to meet the complex needs of patients and surgeons alike.
Products and Services
-
OssDsign Cranial PSI:
This product represents the forefront of patient-specific implant innovation, specifically designed for cranial reconstructions. It consists of a cranial implant tailor-made for each patient, utilizing 3D printing technology to achieve precise anatomical conformity. The implant is made from medical-grade titanium, known for its strength and biocompatibility, ensuring long-term integration and wear resistance. What sets the OssDsign Cranial PSI apart is its unique coating of a regenerative calcium phosphate composition, which promotes bone healing and regeneration, aligning with the body's natural processes for effective cranial reconstruction.
-
OssDsign Catalyst:
An innovative solution for bone grafting, the OssDsign Catalyst caters to the need for effective bone growth stimulation in spinal fusion surgeries. It stands out as an off-the-shelf synthetic bone graft option, designed to seamlessly integrate and stimulate natural bone growth in the surgically treated area. Unlike traditional bone grafts, OssDsign Catalyst is distinguished by its composition and readiness for use, offering a convenient and efficient alternative for surgeons and patients seeking to enhance spinal fusion outcomes through accelerated and supported bone regeneration.
